Gisela Orth Joins QIAGEN as Vice President Global Human Resources
Venlo, The Netherlands, February 5, 2009 - QIAGEN today announced that Gisela Orth has joined the Company as Vice President Global Human Resources on February 2nd. In her new role, she will assume responsibility for the company's global human resource department and all related activities including recruitment, human resources marketing, retention, compensation and benefits, and personnel development. Ms. Orth will be a member of QIAGEN's Executive Committee and will be based at the Company's site in Hilden, Germany.
Ms. Orth brings to QIAGEN almost twenty years of experience in international human resources, including a comprehensive track record in HR management and HR-related consulting. Her most recent position was for the leading automotive supplier Continental as a head of HR. In this role, Ms. Orth took on various assignments in Germany, Eastern Europe, the Middle East and Asia/ Japan, where she successfully created and improved HR processes, led HR related projects and managed HR departments. She holds a MBA from the Edinburg Business School at the Heriot-Watt University, United Kingdom.
"We are very pleased to welcome Gisela in our team", said Peer Schatz, QIAGEN's CEO. "QIAGEN is a recognized employer of choice, and we are proud of our highly-skilled, talented and motivated workforce which is a key to our global success. Our goal always has been and will remain to provide our employees with an industry-leading environment in which they can reach their professional and personal goals. With her impressive track record, Gisela brings an ideal background to this important position and will lead our HR functions and activities and contribute to shaping our unique corporate culture and to leveraging our strengths as employer of choice to enhance the company's long-term growth opportunities through the attraction, development and retention of talent."
QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. QIAGEN has developed and markets more than 500 consumable products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the only FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer. QIAGEN employs more than 3,000 people in over 30 locations worldwide. Further information about QIAGEN can be found at http://www.qiagen.com/.